B-047 Performance Evaluation of Enzymatic HbA1c Assay on Newly Launched Mindray BS-600M Chemistry Analyzer
M Li,Wei‐Fen Xie,Y. Zeng,Anping Xu,Ji Li,Jian Dai
DOI: https://doi.org/10.1093/clinchem/hvad097.390
IF: 12.114
2023-01-01
Clinical Chemistry
Abstract:Background HbA1c has important reference value in risk stratification, diagnosis, therapeutic monitoring and drug selection for diabetic patients. Therefore, the ability to detect HbA1c has attracted much attention. This study was designed to evaluate the performance of the enzymatic HbA1c assay on a newly launched Mindray BS-600M chemistry analyzer, which can be used to measure whole blood samples directly after mixing without centrifugation. Methods Total 309 clinical samples (EDTA anticoagulation) were analyzed using Mindray BS-600M (enzymatic method), Tosoh G8 (HPLC method) and Roche c501 (immunoassay method) analyzers for the performance comparison. And also, the analytical performance of BS-600M, such as precision, accuracy, linearity, interference of conventional interferents, hemoglobin variants, hemoglobin derivatives and common drugs, were evaluated using other fresh whole blood samples, eight frozen calibrators (IFCC) and forty frozen venous whole blood samples (NGSP). Results The within-run and between-run precision of the enzymatic method for HbA1c determination were less than 1% and linearity of HbA1c (%, NGSP unit) was excellent from 2.96% to 20.23%. The deviations between the results of 48 accuracy samples (IFCC and NGSP) and target values were within ±5%, and the sigma metrics of HbA1c at the high and low concentration levels were between 9.9∼19.0, which belongs to the "world-class" level. The results were excellently correlated with those obtained by Tosoh HLC -723 G8 and Roche Cobas c501 (r = 0.997, 0.992). The regression equations of HbA1c was y = 0.979x + 0.005 (n = 198) between BS-600M and G8 and y = 0.934x + 0.317 (n = 112) between BS-600M and c501. The deviation of interference from conventional interferents (bilirubin, Intralipid, vitamin C), hemoglobin variants (HbS, HbC, HbD, HbE), hemoglobin derivatives (LAlc, CarHb, AcetylatedHb), and commonly used antipyretic analgesics and hypoglycemic drugs were all within ±6%, except for the high level HbF (>10%); and also, BS-600M cannot be applied to severe anemia patients (HGB < 45 g/L), which may lead to falsely high HbA1c results. Conclusion The Mindray BS-600M proved to be a robust and reliable method for HbA1c measurement, and was suitable for routine clinical chemistry or hematology laboratory use. In addition, attention or comment need to be added for samples having high HbF concentrations and severe anemia patients in reporting HbA1c% result.